#United States #Philadelphia #Health Innovations #Cancer Care #Daymark Health

Daymark Health Launches with Significant Funding

Daymark Health, a groundbreaking organization in the cancer care sector, has made its official debut with a sizable investment of $11.5 million. This funding was co-led by Maverick Ventures and Yosemite, with valuable contributions from Oncology Ventures. The aim? To revolutionize the cancer care experience for patients, healthcare providers, and insurance plans alike.

Founded this year and operating in collaboration with a prominent payer in the Northeast, Daymark Health plans to deliver evidence-based, supportive cancer care to over 2,500 patients. According to Dr. Justin Bekelman, CEO and Co-Founder, the objective is clear: streamline the fragmented healthcare system that has too long hindered comprehensive, patient-centered care in oncology. He expressed enthusiasm about the launch, emphasizing Daymark’s commitment to setting a new standard in cancer treatment.

The reality of cancer care is sobering, with nearly two million individuals diagnosed annually in the U.S. Statistics show that each patient spends over 8,500 hours outside of the oncology clinic each year, often struggling to manage symptoms, queries, and urgent care needs independently. This is precisely where Daymark Health positions itself – to cater to the clinical, mental, and social needs of cancer patients through its tailored platform and a value-based approach that ensures health plans can effectively manage the total cost of cancer care.

Daymark Health's innovative model brings together a team of nurse practitioners, nurses, social workers, and health partners who collaborate intimately with patients' oncologists and primary care providers. This integrated approach is designed to enhance the experience of care delivery, whether it be through virtual consultations or home visits.

The substantial backing from leading healthcare and oncology investment groups such as Maverick Ventures, Yosemite, and Oncology Ventures will enable Daymark Health to expand its clinical team and accelerate its platform development. Ambar Bhattacharyya, Managing Director at Maverick Ventures, recognized the need for specialty evolving care models for complex populations like cancer patients and expressed excitement about the partnership.

In conjunction with Dr. Bekelman, Daymark Health has assembled a talented team of leaders in oncology and value-based care. Notable figures include Roy Beveridge, the former CMO of Humana, who takes on the role of Executive Board Chair, and Ezekiel Emanuel, a key architect of the Affordable Care Act, serving as Clinical Advisory Board Chair. The company was established through Healthcare Foundry and is driven by co-founders Robert Pahlavan and Jonathan Rhodes, who continue to support operations and growth.

In essence, Daymark Health represents a fresh and vital approach to cancer care, aiming to align patients, healthcare providers, and insurers to ensure personalized care and improved outcomes. The enhanced navigation platform seeks to change how cancer care is delivered, ensuring patients are supported every step of the way.

For further information on Daymark's offerings, visit www.daymarkhealth.com. Their services promise to empower patients with comprehensive care navigation, 24/7 support, mental health services, symptom management, and social support, all accessible both virtually and at home.